In these circumstances, the increased IL-6 levels might be detrimental and correlated with metabolic syndrome and insulin resistance in humans and mice (Mohamed-Ali et al., 1997; Kim et al., 2004; Kim et al., 2012; Wedell-Neergaard et al., 2018). Here, IL6 is linked to metabolic syndrome.